While GSK's vaccine was the first RSV vaccine to be approved by European and U.S. authorities in 2023 for older adults, it has since lagged behind rivals and sales have fallen sharply.

FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains by: Nathaniel Weixel, The Hill Posted: Jun 13, 2025 / 02:08 PM CDT Updated: Jun 13, 2025 / 02:08 PM CDT ...

FDA approves expanded use of Moderna’s RSV shot, but uncertainty remains by: Nathaniel Weixel, The Hill Posted: Jun 14, 2025 / 06:24 PM CDT Updated: Jun 14, 2025 / 06:24 PM CDT ...